141 related articles for article (PubMed ID: 3871172)
1. Lysis of spontaneous murine breast tumors by human interleukin 2-stimulated syngeneic T-lymphocytes.
Merluzzi VJ; Savage DM; Souza L; Boone T; Mertelsmann R; Welte K; Last-Barney K
Cancer Res; 1985 Jan; 45(1):203-6. PubMed ID: 3871172
[TBL] [Abstract][Full Text] [Related]
2. Targeted cytokine production.
Segal DM; Qian JH; Titus JA; Moreno MB; George AJ; Jost CR; Kurucz I; el-Gamil M; Wunderlich JR
Int J Cancer Suppl; 1992; 7():36-8. PubMed ID: 1428400
[TBL] [Abstract][Full Text] [Related]
3. [Tumor-specific cytotoxicity of tumor infiltrating lymphocytes (TIL) induced with TCGF in murine mammary carcinoma].
Hori T; Kan N; Ohgaki K; Yamazaki N; Nakayama N; Nio Y; Inamoto T
Nihon Geka Gakkai Zasshi; 1984 Aug; 85(8):749-57. PubMed ID: 6238229
[TBL] [Abstract][Full Text] [Related]
4. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
5. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
Paciucci PA; Macphail S; Bach FH; Zarling JM
J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
[TBL] [Abstract][Full Text] [Related]
6. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
Paciucci PA; Macphail S; Zarling JM; Bach FH
J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
[No Abstract] [Full Text] [Related]
7. Cycling of immune responses to a syngeneic murine mammary adenocarcinoma.
Huber SA; Bigi G; Lucas ZJ
Cancer Res; 1980 Oct; 40(10):3484-90. PubMed ID: 6449282
[No Abstract] [Full Text] [Related]
8. Genetically targeted T cells eradicate established breast cancer in syngeneic mice.
Wang H; Wei H; Zhang R; Hou S; Li B; Qian W; Zhang D; Kou G; Dai J; Guo Y
Clin Cancer Res; 2009 Feb; 15(3):943-50. PubMed ID: 19188165
[TBL] [Abstract][Full Text] [Related]
9. [The role of thymus gland in the regulation of the activity of peripheral T-lymphocytes in the process of spontaneous blastogenesis in mice].
Stankevich SA; Ogreba VI
Biull Eksp Biol Med; 1990 Apr; 109(4):382-4. PubMed ID: 2143680
[TBL] [Abstract][Full Text] [Related]
10. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
[TBL] [Abstract][Full Text] [Related]
11. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
[No Abstract] [Full Text] [Related]
12. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
Paul RD; Padmanabhan R; Lopez DM
Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
[TBL] [Abstract][Full Text] [Related]
13. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
[TBL] [Abstract][Full Text] [Related]
14. The differentiation of cytotoxic T cells in vitro. IV. Interleukin-2 production in primary mixed lymphocyte cultures involves cooperation between Qa-1+ and Qa-1- "helper" T cells.
Okada M; Stanton TH; Kuppers RC; Henney CS
J Immunol; 1981 Apr; 126(4):1635-9. PubMed ID: 6451650
[TBL] [Abstract][Full Text] [Related]
15. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.
Rosenberg SA; Eberlein TJ; Grimm EA; Lotze MT; Mazumder A; Rosenstein M
Surgery; 1982 Aug; 92(2):328-36. PubMed ID: 6980492
[TBL] [Abstract][Full Text] [Related]
16. Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes.
Salup RR; Toth JA; Hiserodt JC; Wolmark N
Prog Clin Biol Res; 1987; 244():39-48. PubMed ID: 2958875
[No Abstract] [Full Text] [Related]
17. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
Brunner KT; MacDonald HR; Cerottini JC
J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076
[No Abstract] [Full Text] [Related]
18. In vitro studies on splenocyte cytotoxicity against syngeneic mammary carcinomas of mice. 1. Reactivity of splenocytes from mice bearing mammary tumors against the corresponding and against other neoplasms.
More R; Yron I; Weiss DW
Isr J Med Sci; 1978 Jan; 14(1):146-61. PubMed ID: 204609
[No Abstract] [Full Text] [Related]
19. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
Teh HS; Yu M
J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
